Such techniques can be automatically applied using implantable cardioverter defibrillators (ICDs) and offer the potential for painless termination of ventricular tachycardia (VT). Reduction in ...

Implantable cardiac devices play a significant role in decreasing the morbidity and mortality in patients with cardiovascular disease. Tissue-device interactions leading to systemic ...

Tylon Lott, a junior for the Holy Cross High School basketball team in Waterbury, collapsed shortly after a game at Kennedy ...

Kestra Medical recently filed a form S-1 to confirm its intent to go public through an initial public offering (IPO).

The first cardioverter-defibrillator, invented and developed by Polish-born Israeli-American physician Michel Mirowski, was implanted in a patient at Johns Hopkins Hospital. Since then ...

Complex care needs, respiratory illnesses playing a role: in other hospital news, SAH cardiac program seeks Type 1 status to ...

Heart disease is more common in people over 65, but treatments are better than ever. That can complicate decision-making for ...

Kestra Medical Technologies announced today that it appointed Al Ford as its new chief commercial officer (CCO).

Over the past decades, hypertrophic cardiomyopathy has become a contemporary treatable disease. However, limited data exist on the global trends of implantable cardioverter defibrillator (ICD) ...

A Guide" provides compassionate guidance on the ethical, medical, and emotional considerations of deactivating a pacemaker ...